Azzad Asset Management Inc /Adv Bristol Myers Squibb CO Transaction History

Azzad Asset Management Inc /Adv

$891 Billion
Q3 2024

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Apr 01, 2024	BUY	$48.48 - $57.85 $8,144 - $9,718	168 Added 0.89%	18,953 $972 Million
Q3 2023 Apr 01, 2024	SELL	$57.89 - $64.73 $2,547 - $2,848	-44 Reduced 0.23%	18,785 $1.09 Billion
Q2 2023 Apr 01, 2024	SELL	$63.71 - $70.74 $727,058 - $807,284	-11,412 Reduced 37.74%	18,829 $1.2 Billion
Q1 2023 Apr 01, 2024	BUY	$65.71 - $74.53 $31,343 - $35,550	477 Added 1.6%	30,241 $2.1 Billion
Q4 2022 Apr 01, 2024	SELL	$68.48 - $81.09 $52,729 - $62,439	-770 Reduced 2.52%	29,764 $2.14 Billion
Q3 2022 Apr 01, 2024	SELL	$0.13 - $76.84 $690 - $408,404	-5,315 Reduced 14.83%	30,534 $2.16 Billion
Q2 2022 Apr 01, 2024	SELL	$72.62 - $79.98 $401,661 - $442,369	-5,531 Reduced 13.37%	35,849 $2.75 Billion
Q1 2022 Apr 01, 2024	BUY	$61.48 - $73.72 $143,924 - $172,578	2,341 Added 6.0%	41,380 $3.02 Billion
Q4 2021 Apr 01, 2024	BUY	$53.63 - $62.52 $34,269 - $39,950	639 Added 1.66%	39,039 $2.43 Billion
Q3 2021 Apr 01, 2024	BUY	$59.17 - $69.31 $483,418 - $566,262	8,170 Added 27.03%	38,400 $2.27 Billion
Q2 2021 Apr 01, 2024	BUY	$61.91 - $67.42 $57,947 - $63,105	936 Added 3.2%	30,230 $2.02 Billion
Q1 2021 Apr 01, 2024	BUY	$59.34 - $66.74 $1.74 Million - $1.96 Million	29,294 New	29,294 $1.85 Billion
Q3 2019 Apr 01, 2024	SELL	$42.77 - $50.71 $831,363 - $985,700	-19,438 Closed	0 $0
Q2 2019 Apr 01, 2024	SELL	$44.62 - $49.34 $8,076 - $8,930	-181 Reduced 0.92%	19,438 $882 Million
Q1 2019 Apr 01, 2024	BUY	$45.12 - $53.8 $9,475 - $11,298	210 Added 1.08%	19,619 $936 Million
Q4 2018 Apr 01, 2024	BUY	$48.76 - $63.23 $169,684 - $220,040	3,480 Added 21.85%	19,409 $1.01 Billion
Q3 2018 Apr 01, 2024	SELL	$55.19 - $62.25 $3,090 - $3,486	-56 Reduced 0.35%	15,929 $989 Million
Q2 2018 Apr 01, 2024	BUY	$50.53 - $62.98 $807,722 - $1.01 Million	15,985 New	15,985 $885 Million
Q1 2018 Apr 03, 2024	BUY	$59.92 - $68.98 $46,438 - $53,459	775 Added 5.21%	15,655 $990 Million
Q4 2017 Apr 03, 2024	BUY	$59.94 - $65.35 $51,488 - $56,135	859 Added 6.13%	14,880 $912 Million
Q3 2017 Apr 03, 2024	BUY	$55.23 - $63.74 $68,153 - $78,655	1,234 Added 9.65%	14,021 $894 Million
Q2 2017 Apr 03, 2024	BUY	N/A	1,435 Added 12.64%	12,787 $712 Million
Q1 2017 Apr 03, 2024	BUY	N/A	3,701 Added 48.37%	11,352 $617 Million
Q4 2016 Apr 03, 2024	BUY	N/A	381 Added 5.24%	7,651 $447 Million
Q3 2016 Apr 03, 2024	BUY	N/A	1,440 Added 24.7%	7,270 $392 Million
Q2 2016 Apr 03, 2024	SELL	N/A	-13,123 Reduced 69.24%	5,830 $429 Million
Q3 2012 Apr 08, 2024	SELL	N/A	-12,469 Closed	0 $0
Q2 2012 Apr 08, 2024	BUY	N/A	1,224 Added 10.88%	12,469 $448 Million
Q1 2012 Apr 08, 2024	SELL	N/A	-4,953 Reduced 30.58%	11,245 $380 Million
Q4 2011 Apr 08, 2024	BUY	N/A	205 Added 1.28%	16,198 $571 Million
Q3 2011 Apr 08, 2024	SELL	N/A	-834 Reduced 4.96%	15,993 $502 Million
Q2 2011 Apr 08, 2024	SELL	N/A	-2,126	16,827 $487 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Account